Institutional Fund
Lion Point Capital, LP
New York, NYCIK 16433545 filings on record
Portfolio Value
$16.73M
Q1 2026
Holdings
35
Reported positions
New Buys
0
Opened this quarter
QoQ Change
-13.4%
from $19.32M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Praxis Precision Medicines I8.6%
- Moonlake Immunotherapeutics7.5%
- Royalty Pharma PLC6.1%
- Milestone Pharmaceuticals In5.8%
- Geron Corp5.1%
- Syndax Pharmaceuticals Inc5.0%
- Other61.8%
Portfolio Holdings
35 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Praxis Precision Medicines I | 4.5K | $1.43M | 8.6% | 0 | Held |
| 2 | Moonlake Immunotherapeutics | 67.5K | $1.26M | 7.5% | 0 | Held |
| 3 | Royalty Pharma PLC | 21.4K | $1.03M | 6.1% | 0 | Held |
| 4 | Milestone Pharmaceuticals In | 820.0K | $975.8K | 5.8% | +65.0K | Added |
| 5 | Geron Corp | 578.0K | $861.2K | 5.1% | 0 | Held |
| 6 | Syndax Pharmaceuticals Inc | 36.0K | $841.0K | 5.0% | 0 | Held |
| 7 | Ardelyx Inc | 128.7K | $770.6K | 4.6% | 0 | Held |
| 8 | Fennec Pharmaceuticals Inc | 112.4K | $691.5K | 4.1% | 0 | Held |
| 9 | Benitec Biopharma Inc | 62.0K | $660.3K | 3.9% | 0 | Held |
| 10 | Sarepta Therapeutics Inc | 28.5K | $620.2K | 3.7% | 0 | Held |
25 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio